PDL BioPharma, Inc. Operating Leases, Future Minimum Payments Due
PDL BioPharma, Inc. had Operating Leases, Future Minimum Payments Due of $2.70 million as of 2018-12-31, per its 8-K filed 2020-06-29.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDue · last filed 2020-06-29
- 2018-12-31: Operating Leases, Future Minimum Payments Due $2.70M.
- 2017-12-31: Operating Leases, Future Minimum Payments Due $3.84M.
- 2016-12-31: Operating Leases, Future Minimum Payments Due $505.00K.
- 2015-12-31: Operating Leases, Future Minimum Payments Due $246.00K.
| Period end | Operating Leases, Future Minimum Payments Due |
|---|---|
| 2018-12-31 | $2.70M 8-K · filed 2020-06-29 |
| 2017-12-31 | $3.84M 10-K · filed 2018-03-16 |
| 2016-12-31 | $505.00K 10-K · filed 2017-03-01 |
| 2015-12-31 | $246.00K 10-K · filed 2016-02-23 |
| 2014-12-31 | $322.00K 10-K · filed 2015-02-23 |
| 2013-12-31 | $134.00K 10-K · filed 2014-03-03 |
| 2012-12-31 | $369.00K 10-K · filed 2013-03-01 |
| 2012-09-30 | $103.00M 10-Q · filed 2012-11-05 |
| 2012-06-30 | $105.60M 10-Q · filed 2012-08-02 |
| 2012-03-31 | $108.20M 10-Q · filed 2012-05-03 |
| 2011-12-31 | $259.00K 10-K · filed 2012-02-23 |
| 2011-06-30 | $115.90M 10-Q · filed 2011-07-29 |